0001867096-24-000124 Sample Contracts
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 8th, 2024 • Xeris Biopharma Holdings, Inc. • Pharmaceutical preparations • Delaware
This Second Amended and Restated Employment Agreement (“Agreement”) is made as of July 7, 2024, by and among Xeris Biopharma Holdings, Inc., a Delaware corporation (the “Parent”), Xeris Pharmaceuticals, Inc., a Delaware corporation and wholly-owned subsidiary of the Parent (the “Company”), and John Shannon (the “Executive”) and is effective as of August 1, 2024 (the “Effective Date”)
July 7, 2024 Paul R. Edick Re: Transition Agreement Dear Paul:Transition Agreement • July 8th, 2024 • Xeris Biopharma Holdings, Inc. • Pharmaceutical preparations • Illinois
This letter confirms our agreement regarding your transition from the role of Chief Executive Officer of Xeris Biopharma Holdings Inc., a Delaware corporation (the “Parent”), and Xeris Pharmaceuticals, Inc., a Delaware corporation and wholly owned subsidiary of the Parent (the “Company”) and your future services as a Senior Advisor. The Board of Directors of the Parent (the “Board”) appreciates your substantial contributions to the Company, looks forward to your support as a Senior Advisor, and would like to make the transition to the Company’s new Chief Executive Officer (the “New CEO”) as seamless as possible.